Financial News
Latest News about BCRX
Recent news which mentions BCRX
Tickers
BCRX
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
April 21, 2022
Tags
Stocks to Buy
NASDAQ:BNTX,NASDAQ:BCRX,NASDAQ:MRNA,NASDAQ:MRUS,NASDAQ:ITOS,NASDAQ:EXEL,NASDAQ:RGNX,NYSE:PFE
Market News
From InvestorPlace
Tickers
BCRX
From Motley Fool
From Benzinga
Why BioChryst Pharmaceuticals' Stock Jumped 14.7% This Week
April 14, 2022
Tickers
BCRX
From Motley Fool
28 Biggest Movers From Yesterday
April 14, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 11, 2022
From Benzinga
Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16
April 11, 2022
Tickers
BCRX
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 08, 2022
From Benzinga
28 Stocks Moving In Friday's Mid-Day Session
April 08, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 08, 2022
From Benzinga
From Benzinga
Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder
April 08, 2022
Tickers
BCRX
From Benzinga
Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February
April 08, 2022
From Benzinga
BioCryst's Orladeyo Shows Long Term Benefit With Sustained Reductions in Attack Rates
February 24, 2022
Tickers
BCRX
From Benzinga
BioCryst Pharmaceuticals (BCRX) Q4 2021 Earnings Call Transcript
February 23, 2022
Tickers
BCRX
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
